SMYD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.815410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.270300E-02
Normal-vs-Stage2
1.254620E-01
Normal-vs-Stage3
1.965950E-02
Normal-vs-Stage4
3.161200E-01
Stage1-vs-Stage2
4.335000E-01
Stage1-vs-Stage3
2.784800E-01
Stage1-vs-Stage4
5.230600E-01
Stage2-vs-Stage3
6.286100E-02
Stage2-vs-Stage4
8.611200E-01
Stage3-vs-Stage4
1.693190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.047800E-01
Normal-vs-AfricanAmerican
2.817200E-01
Normal-vs-Asian
3.137800E-02
Caucasian-vs-AfricanAmerican
6.662400E-01
Caucasian-vs-Asian
5.187800E-01
AfricanAmerican-vs-Asian
2.659000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.464600E-01
Normal-vs-Female
1.216180E-01
Male-vs-Female
5.483000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.084400E-02
Normal-vs-Age(41-60Yrs)
1.934990E-01
Normal-vs-Age(61-80Yrs)
1.960780E-01
Normal-vs-Age(81-100Yrs)
2.392400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.310600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.017200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.785620E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.929000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.872400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.496800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.158400E-01
Normal-vs-Daily Drinker
6.618200E-02
Normal-vs-Weekly Drinker
4.616300E-02
Normal-vs-Occasional Drinker
5.534000E-01
Normal-vs-Social Drinker
2.977200E-01
Non Drinker-vs-Daily Drinker
2.100600E-01
Non Drinker-vs-Weekly Drinker
6.765600E-01
Non Drinker-vs-Occasional Drinker
3.260600E-01
Non Drinker-vs-Social Drinker
6.631000E-01
Daily Drinker-vs-Weekly Drinker
4.353800E-01
Daily Drinker-vs-Occasional Drinker
5.438500E-02
Daily Drinker-vs-Social Drinker
1.325390E-01
Weekly Drinker-vs-Occasional Drinker
1.878590E-01
Weekly Drinker-vs-Social Drinker
3.943200E-01
Occasional Drinker-vs-Social Drinker
6.309000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.393600E-01
Normal-vs-Grade 2
4.270300E-02
Normal-vs-Grade 3
3.808100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.203000E-01
Grade 1-vs-Grade 3
4.041800E-01
Grade 1-vs-Grade 4
2.393600E-01
Grade 2-vs-Grade 3
9.537600E-03
Grade 2-vs-Grade 4
4.270300E-02
Grade 3-vs-Grade 4
3.808100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.450990E-01
Normal-vs-NonDiabetic
2.440200E-01
Diabetic-vs-NonDiabetic
1.328220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.333700E-02
Normal-vs-NoPancreatitis
2.225600E-01
Pancreatitis-vs-NoPancreatitis
7.425000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.253800E-01
Normal-vs-N1
1.077200E-01
N0-vs-N1
2.590400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.482600E-01
Normal-vs-TP53-NonMutant
2.740400E-01
TP53-Mutant-vs-TP53-NonMutant
4.104300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
